Literature DB >> 7444518

Malignant melanoma associated with breast cancer.

B S Schoenberg, B W Christine.   

Abstract

The experience of the population-based Connecticut Tumor Registry was analyzed for the occurrence in the same patient of breast cancer and malignant melanoma. A total of 18,010 women with breast cancer were followed up for the subsequent development of malignant melanoma of the skin or eye. Similarly, 835 women with cutaneous or ocular malignant melanoma were followed up for the subsequent development of breast carcinoma. Survival experience for these cohorts and appropriate Connecticut Tumor Registry incidence rates were used to calculate an expected number of individuals with both types of malignant neoplasms. Twenty-three women had both types of tumors diagnosed at least one month apart. Fewer than 14 such occurrences were expected (P < .05). The two tumors may be related through hormonal factors, particularly when considered with regard to the findings of other laboratory and epidemiologic studies.

Entities:  

Mesh:

Year:  1980        PMID: 7444518     DOI: 10.1097/00007611-198011000-00023

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

Review 1.  Risk factors for intraocular melanoma and occupational exposure.

Authors:  J M Lutz; I A Cree; A J Foss
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

Review 2.  Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.

Authors:  Elizabeth Ann L Enninga; Shernan G Holtan; Douglas J Creedon; Roxana S Dronca; Wendy K Nevala; Simona Ognjanovic; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

3.  Racial and age differences in multiple primary cancers after breast cancer: a population-based analysis.

Authors:  A G Schwartz; N E Ragheb; G M Swanson; W A Satariano
Journal:  Breast Cancer Res Treat       Date:  1989-11       Impact factor: 4.872

4.  A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use.

Authors:  M R Karagas; T A Stukel; J Dykes; J Miglionico; M A Greene; M Carey; B Armstrong; J M Elwood; R P Gallagher; A Green; E A Holly; C S Kirkpatrick; T Mack; A Østerlind; S Rosso; A J Swerdlow
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

5.  Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study.

Authors:  R P Gallagher; J M Elwood; G B Hill; A J Coldman; W J Threlfall; J J Spinelli
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

6.  Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.

Authors:  C Wassberg; M Thörn; J Yuen; U Ringborg; T Hakulinen
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.